FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
-0.09%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$17.9B
AUM Growth
+$17.9B
(-3.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
39.72%
Holding
164
New
17
Increased
41
Reduced
26
Closed
19
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$403M |
| 2 |
Microsoft
MSFT
|
$245M |
| 3 |
Salesforce
CRM
|
$203M |
| 4 |
Aramark
ARMK
|
$167M |
| 5 |
Walt Disney
DIS
|
$105M |
Top Sells
| 1 |
Airbnb
ABNB
|
$319M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
$221M |
| 3 |
Bristol-Myers Squibb
BMY
|
$180M |
| 4 |
HES
Hess
HES
|
$163M |
| 5 |
JNPR
Juniper Networks
JNPR
|
$142M |
Sector Composition
| 1 | Healthcare | 42.73% |
| 2 | Technology | 17.47% |
| 3 | Financials | 14.39% |
| 4 | Communication Services | 7.16% |
| 5 | Industrials | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HES
1
DELISTED
Hess
HES
| $867M | 4.3% | 5,425,000 -1,020,000 | -16% | -$163M |
|
|
2
Microsoft
MSFT
$3.77T
| $858M | 4.26% | 2,285,835 +652,688 | +40% | +$245M |
|
3
Exelixis
EXEL
$10.1B
| $832M | 4.13% | 22,533,500 -906,000 | -4% | -$33.4M |
|
|
DFS
4
DELISTED
Discover Financial Services
DFS
| $816M | 4.05% | 4,780,000 +520,000 | +12% | +$88.8M |
|
5
UnitedHealth
UNH
$281B
| $785M | 3.89% | 1,497,900 +35,400 | +2% | +$18.5M |
|
6
Natera
NTRA
$23.1B
| $643M | 3.19% | 4,547,809 +116,200 | +3% | +$16.4M |
|
7
IQVIA
IQV
$32.4B
| $602M | 2.98% | 3,411,851 +288,700 | +9% | +$50.9M |
|
8
Lantheus
LNTH
$3.73B
| $588M | 2.92% | 6,023,227 +707,000 | +13% | +$69M |
|
|
9
Aramark
ARMK
$10.3B
| $561M | 2.78% | 16,241,996 +4,831,656 | +42% | +$167M |
|
|
10
Walt Disney
DIS
$213B
| $542M | 2.69% | 5,496,223 +1,068,155 | +24% | +$105M |
|
|
11
Salesforce
CRM
$245B
| $528M | 2.62% | 1,967,110 +756,972 | +63% | +$203M |
|
12
Autodesk
ADSK
$67.3B
| $523M | 2.59% | 1,997,400 +155,600 | +8% | +$40.7M |
|
13
Intuit
INTU
$186B
| $516M | 2.56% | 840,258 +86,500 | +11% | +$53.1M |
|
14
Thermo Fisher Scientific
TMO
$186B
| $515M | 2.56% | 1,035,856 -197,400 | -16% | -$98.2M |
|
15
Revolution Medicines
RVMD
$7.1B
| $479M | 2.37% | 13,534,692 +286,000 | +2% | +$10.1M |
|
16
TransUnion
TRU
$17.2B
| $449M | 2.23% | 5,413,206 +86,887 | +2% | +$7.21M |
|
17
New York Times
NYT
$9.74B
| $443M | 2.2% | 8,932,113 +1,556,000 | +21% | +$77.2M |
|
|
ITCI
18
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $403M | 2% | +3,055,000 | New | +$403M |
|
19
Boston Scientific
BSX
$156B
| $380M | 1.88% | 3,762,757 -1,260,200 | -25% | -$127M |
|
20
Aon
AON
$79.1B
| $378M | 1.88% | 1,361,744 -470,989 | -26% | -$131M |
|
21
McKesson
MCK
$85.4B
| $372M | 1.84% | 552,500 -58,200 | -10% | -$39.2M |
|
22
Nasdaq
NDAQ
$54.4B
| $338M | 1.68% | 4,460,288 +462,269 | +12% | +$35.1M |
|
23
CBRE Group
CBRE
$48.2B
| $326M | 1.62% | 2,495,700 +315,900 | +14% | +$41.3M |
|
|
ANSS
24
DELISTED
Ansys
ANSS
| $300M | 1.49% | 948,000 | – | – |
|
25
Charles Schwab
SCHW
$174B
| $300M | 1.49% | 3,832,857 +663,857 | +21% | +$52M |
|